Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromobox homolog 4 (CBX4) is a nuclear protein that belongs to the polycomb group (PcG) family and functions as both a component of the PRC1 complex and as a SUMO E3 ligase[1][2][3][4][5]. Its chromodomain enables specific binding to di- and trimethylated lysines (H3K27me3, H3K9me3) on histone H3, facilitating gene silencing and maintenance of cell identity[2]. In addition, CBX4 contains SUMO-interacting motifs (SIMs) and a conserved Pc box. CBX4 is required for diverse processes including transcriptional silencing, DNA damage repair, cell cycle regulation, and cell proliferation[2][3]. It plays context-dependent roles in cancer, with evidence for both tumor suppressive and oncogenic activities: for example, it suppresses metastasis via HDAC3 recruitment in colorectal carcinoma, while promoting progression and stemness in hepatocellular carcinoma by enhancing HIF-1α sumoylation and VEGF expression[1][5][7]. CBX4 is also implicated in regulating cellular senescence and response to ionizing radiation through sumoylation-mediated DNA damage repair pathways[2][3]. No approved drugs currently target CBX4, though chemical probes (e.g., UNC3866) have been developed for research applications[6]. If further structure-specific or pathway-related information is needed, note that CBX4 functions through the PRC1 complex and its own SUMO E3 ligase activity, both critical for its biological roles[2][3][4][5][7].
Modulation of gene expression through chromodomain-mediated binding to methylated histone H3 (H3K27me3/H3K9me3). SUMOylation of target proteins, e.g., BMI1, facilitating DNA damage repair. Recruitment of histone deacetylase 3 (HDAC3), leading to histone deacetylation and transcriptional repression (e.g., suppression of Runx2). Regulation of cellular senescence and stemness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromobox homolog 4 (CBX4).